Publicacións en colaboración con investigadores/as de Clínica Universitaria de Navarra (14)

2024

  1. Current Management and Future Perspectives in Metastatic HER2-Positive Breast Cancer

    Seminars in Oncology Nursing, Vol. 40, Núm. 1

  2. Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line

    Clinical and Translational Oncology

2020

  1. Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO)

    Gynecologic Oncology Reports, Vol. 33

2019

  1. Assessing the impact of the addition of dendritic cell vaccination to neoadjuvant chemotherapy in breast cancer patients: A model-based characterization approach

    British Journal of Clinical Pharmacology, Vol. 85, Núm. 8, pp. 1670-1683

2017

  1. A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients

    Journal of Translational Medicine, Vol. 15, Núm. 1

2016

  1. Long-Term Results of a Phase II Trial of Concomitant Cisplatin-Paclitaxel Chemoradiation in Locally Advanced Cervical Cancer

    International Journal of Gynecological Cancer, Vol. 26, Núm. 6, pp. 1162-1168

2014

  1. MYH polyposis syndrome: Clinical findings, genetics issues and management

    Clinical and Translational Oncology, Vol. 16, Núm. 8, pp. 675-679

2010

  1. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer

    International Journal of Gynecological Cancer, Vol. 20, Núm. 1, pp. 133-140

  2. Sequential administration of dose-dense epirubicin/cyclophosphamide followed by docetaxel/capecitabine for patients with HER2-negative and locally advanced or node-positive breast cancer

    Cancer Chemotherapy and Pharmacology, Vol. 65, Núm. 3, pp. 457-465

2009

  1. Pregnancy associated breast cancer

    European Journal of Surgical Oncology, Vol. 35, Núm. 2, pp. 215-218

  2. Sensory-motor axonal peripheral neuropathy in an advanced breast cancer patient treated with ixabepilone

    Clinical and Translational Oncology, Vol. 11, Núm. 11, pp. 765-766

2008

  1. Preliminary results of the combination of bevacizumab and weekly paclitaxel in advanced melanoma

    Oncology, Vol. 74, Núm. 1-2, pp. 12-16

2007

  1. Is there any reason to delay introduction of tumor necrosis factor in the management of in-transit metastasis of unresectable melanoma? [13]

    Journal of Clinical Oncology

2006

  1. Idiopathic hyperammonemia following high-dose chemotherapy [2]

    Bone Marrow Transplantation